S-Biomedic brings novel therapeutic solutions to the skin microbiome.
The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing.
S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries.
We design our products using the latest advances in microbiology and dermatology. Using our technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, we are able to restore a healthy state back to your skin.
Our first target is acne vulgaris, one of the many skin diseases linked to the distortion of the microbiome.
Location: Belgium, Antwerp
Employees: 11-50
Total raised: $1.16M
Founded date: 2014
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.09.2021 | Grant | $1.16M | - |